Poster session 1
SARS-CoV-2 and other coronaviruses

Programm

• • Poster Presentation
  • PP 073

  Paper-based microfluidic device for rapid and on-site virus detection

  • Dr. Zhugen Yang (Milton Keynes / GB)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 074

  A paper sensor for viral RNA and protein detection for SARS-CoV-2 in saliva

  • Dr. Zhugen Yang (Milton Keynes / GB)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 075

  Retrospective screening of SARS-CoV-2 antibodies in cerebrospinal fluid samples of patients with neurological manifestations of unknown aetiology in a tertiary care hospital during the pandemic period

  • Dr. Amrita Pattanaik (Udupi / IN)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 076

  Adaptive immune response to different combinations of SARS-CoV-2 vaccination and breakthrough infection

  • Dr. Jernej Pusnik (Bonn / DE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 077

  Development of a high-throughput neutralization assay for SARS-CoV-2 and its application in the assessment of the antibody response in a cohort of vaccinated pregnant women

  • Gabriela Mattoso Coelho (Curitiba / BR)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 078

  Understanding SARS-CoV-2 transmission, infection and susceptibility in neovison vison

  • Vinaya Venkat (Helsinki / FI)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 079

  SARS-CoV-2 inhibiting antibodies were discovered in the sera of one leopard and two rhinoceros during serosurveillance on Dvůr Králové Zoo animals

  • Dr. Jignesh Italiya (Prague / CZ)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 080

  Epidemiological and pathophysiological assessment of Coronavirus disease (COVID-19) patients – a retrospective study

  • Dr. Niamatullah Kakar (Turbat / PK)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 081

  SARS-CoV-2 infection landscape and antiviral drug effects in airway multiciliated epithelium derived from iPSC

  • Lisa Morichon (Montpellier / FR)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 082

  Impact of Ace2 and Tmprss2 polymorphisms on Covid-19 severity in a subset of Pakistani population

  • Dr. Santosh Kumar Sidhwani (Karachi / PK)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 083

  Proteomic analysis of human non-small cell lung carcinoma (LC-HK2) infected with SARS-COV2

  • Dr. Thatiana Melo (São Paulo / BR)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 084

  Proteomic analysis of THP1-derived macrophages infected with SARS-CoV-2

  • Dr. Hellen Valerio (São Paulo / BR)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 085

  Cytokine deficiencies in persons with Long-COVID

  • Professor Vicente Planelles (Salt Lake City, UT / US)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 086

  In Vivo models for evaluating a pharmaceutical drug against SARS-CoV-2

  • Chiho Yu (Daejeon / KR)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 087

  Stepping up in immunomonitoring – EliSpot five colour cytokine release assay

  • Rosemarie Preyer (Strassberg / DE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 089

  Humoral responses following SARS-CoV-2 vaccination with homologous doses of CoronaVac, ChAdOx1 or BTN162B2 in people living with HIV

  • Susann Hohensee (Luebeck / DE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 095

  Relevance of SARS-CoV-2 accessory genes to virulence in a transgenic mouse model of infection

  • Jesus Hurtado-Tamayo (Madrid / ES)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 096

  Novel CRISPR-Cas13d system to target highly conserved sequences of SARS-CoV-2 and other human coronaviruses

  • Mouraya Hussein (Amsterdam / NL)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 097

  Development of an automated assay for the quantitative detection of neutralizing antibodies against SARS-CoV-2

  • Fabien Fulmar (Marcy l'Etoile / FR)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 098

  Meta-analysis of genome-wide CRISPR screens reveals RAB9A as a SARS-CoV-2 entry factor

  • Yannick Stahl (Heidelberg / DE)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 099

  Identification of new B cell epitopes in the stem helix region in S2 domain of the Spike protein with different degrees of conservation among human and animal beta-coronavirus

  • Dr. Kah Man Lai (Singapore / SG)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 100

  Validation of the K18-hACE2 humanized mouse model of SARS-CoV-2 for preclinical screening of antiviral therapeutics

  • Dr. Yvette Kazungu (Liverpool / GB)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 101

  Memory T-cell epitope-based peptide vaccine candidates against Middle East Respiratory Syndrome Coronavirus

  • Dr. Hyun-Joo Kim (Cheongju-si / KR)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 102

  Small interfering RNA effectively inhibit the SARS-CoV-2 infection

  • Dr. Se Hun Gu (Daejeon / KR)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 103

  Structural and functional mechanism of SARS-CoV-2 cell entry

  • Tea Govednik (Ljubljana / SI)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 104

  Antioxidant compounds inhibit SARS-CoV-2 cell entry and mitigate inflammation

  • Tea Govednik (Ljubljana / SI)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 105

  Comparison of biological and biochemical neutralization tests to detect neutralizing antibodies to SARS-CoV-2

  • Sari Maljanen (Turku / FI)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 106

  Seasonal coronavirus infection and reinfection rates in early childhood in Southwest Finland

  • Pekka Kolehmainen (Turku / FI)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 107

  Emergency preparedness and integrated surveillance potential of a rapid COVID-19 diagnostic for airport quarantine in Bangladesh

  • Dr. Muhammad Asaduzzaman (Oslo / NO)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 108

  Direct lysis RT-qPCR-based RNAi screen of SARS-CoV-2 production reveals host genes involved in the entire replication cycle

  • Alison Daniels (Edinburgh / GB)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 109

  RNA-based regulation of the interferon immune response during SARS-CoV-2 infection

  • Marco Antonio Olguin Nava (Wuerzburg / DE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 110

  Mapping the viral entry platforms in 3D tissue cultures

  • Dr. Katarzyna Owczarek (Cracow / PL)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 111

  High prevalence of undocumented SARS-CoV-2 infections in the pediatric population of the tyrolean district of Schwaz

  • Dr. Barbara Falkensammer (Innsbruck / AT)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 112

  Evaluation of in-vitro and in-vivo antiviral activities of vitamin D for SARS CoV-2 and variants

  • Dr. Yan Ling Ng (Singapore / SG)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 113

  Pre-existing titers of neutralizing antibodies determine the risk of SARS-CoV-2 Omicron breakthrough infections

  • Catharina Christa (Munich / DE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 114

  Molecular docking study of Beta amyrin from mangrove against SARS-CoV-2 proteins

  • R. Purushothaman (Chidambaram / IN)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 116

  Detection of SARS-CoV-2 variants by different diagnostics assays

  • Dr. Anna Rosa Garbuglia (Rome / IT)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 117

  Investigating the role of stress granules in virus infection

  • Reto Lang (Bern / CH)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 118

  The evolving network of associated SARS-CoV-2 spike variable positions – from cliques and communities to constellations of key substitutions in emerging variants

  • Dr. Cleo Anastassopoulou (Athens / GR)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 119

  A novel 3CLpro luciferase reporter assay allowing the identification of coronavirus protease inhibitors

  • Dr. Dorota Kmiec (Ulm / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 120

  Baseline plasma SARS-CoV-2 RNA viral load predicts an adverse COVID-19 evolution in hospitalized patients with moderate to severe disease

  • Dr. Paolo Ravanini (Novara / IT)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 121

  BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies

  • Professor Guruprasad Medigeshi (Faridabad / IN)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 122

  Effectiveness of ceiling-mounted ultraviolet lamps – an experimental study

  • Jeong Young Lee (Seoul / KR)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 123

  Usefulness of the rapid antigen test in detecting severe acute respiratory syndrome coronavirus 2 for infection control in hospitals

  • Jeong Young Lee (Seoul / KR)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 124

  Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes

  • Dr. Rayhane Nchioua (Ulm / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 125

  Molecular analyses of clinical isolates and recombinant SARS-CoV-2 carrying B.1 and B.1.617.2 spike mutations suggest a potential role of non-spike mutations in infection kinetics

  • Maximilian A. Kelch (Frankfurt / DE)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 126

  Investigation of the entry pathways of SARS-CoV-2 by using fluorescence-labelling SARS-CoV-2 Virus-like particles

  • Dr. Li-Wei Chu (Taipei City / TW)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 127

  The roles of CCR5 in SARS-CoV-2 infection

  • Dr. Po-Ru Chen (Taipei City / TW)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 128

  Genetic epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland

  • Professor Tomasz Wąsik (Sosnowiec / PL)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 129

  Individuals with Long COVID – sustained immune alterations after a 6-month period

  • Clara Sánchez-Menéndez (Majadahonda / ES)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 130

  The 'true' scale of COVID-19 pandemic – the longitudinal quantitative and qualitative analysis on the SARS-CoV-2 in the wastewater in Poznan, Poland

  • Dr. Pawel Zmora (Poznan / PL)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 131

  Distinctly lower sensitivity of Golden Syrian hamsters to SARS-CoV-2 Omicron BA.2 as compared to the ancestral strain 2019_nCoV Muc-IMB-1

  • Dr. Anne Balkema-Buschmann (Greifswald – Insel Riems / DE)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 132

  An RNA replicon system to investigate promising inhibitors of feline infectious peritonitis Coronavirus

  • Kimberly S. Schmied (Bern / CH)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 133

  High levels of soluble endothelial cell protein C receptor in plasma of individuals with Long-COVID proves the role of endothelial dysfunction in the persistence of COVID-19

  • Alicia Simón-Rueda (Majadahonda / ES)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 134

  RIG-I-like receptor gene polymorphisms in patients hospitalized due to COVID-19

  • Dariusz Jarych (Lodz / PL)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 135

  Frequency of TLR3, 7 and 8 gene polymorphisms in patients with moderate and severe COVID-19

  • Professor Edyta Paradowska (Lodz / PL)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 136

  Cellular translation and splicing associated factors cleaved by the coronavirus proteases

  • Professor Guigen Zhang (Guangzhou / CN)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 137

  Assessment of circulation of SARS-COV-2 and other coronaviruses in dogs and cats in Italy

  • Dr. Donato Raele (Foggia / IT)
  • Dr. Nicola Cavaliere (Foggia / IT)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 138

  Generation of SARS-CoV-2 variants from RNA using a combined ARTIC-TAR system

  • Dr. Bettina S. Trüeb (Bern / CH)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 139

  Whole virion purification of SARS-CoV-2 for immunological studies

  • Balazs Antal Somogyi (Pécs / HU)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 140

  Novel molecular targets – structural evaluation of the SARS-CoV-2 M^pro oligomerization

  • Kinga Lis (Cracow / PL)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 141

  Cytokine profiles in patients with mild and severe COVID-19

  • Professor Edyta Paradowska (Lodz / PL)
  • Dariusz Jarych (Lodz / PL)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 142

  Development of a flow cytometry-based micro-neutralisation assay to elavuate humoral immunity against SARS-COV-2 variants of concern in vaccine trials

  • Sophie O'Reilly (Dublin / IE)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 143

  Fragment screening against the SARS-CoV-2 macrodomain

  • Dr. Frank Lennartz (Berlin / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 144

  The SUMO pathway targets SARS-CoV-2 replication and is a potential target for antiviral development

  • Leah Ennis McLoughlin (Dublin / IE)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 145

  SARS-CoV-2 hijacks the host mRNA m6Am cap methylase to sustain viral replication

  • Dr. Nadine Ebert (Bern / CH)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 146

  Problem of normalisation the concentration of SARS-CoV-2 RNA in wastewater samples on example every week analysis of samples collected in Czajka, Warsaw, Poland

  • Prof. Dr. Katarzyna Pancer (Warsaw / PL)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 147

  SARS-CoV-2 detection in aircraft wastewater – a new challenge

  • Klaudia Ordyniak (Warsaw / PL)
  • Prof. Dr. Katarzyna Pancer (Warsaw / PL)

   One Health, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 148

  SARS-CoV-2 cell entry, infection and host targeting antivirals

  • Ravi Ojha (Helsinki / FI)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 149

  The role of membrane complexity in the early entry stages of SARS-CoV-2 variants

  • Dario Conca (Umeå / SE)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 150

  Genomic stability evaluation of SARS-CoV-2 lineages suggests higher evolutionary rate of the early strains

  • Dr. Gediminas Alzbutas (Kaunas / LT)

   SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
• • Poster Presentation
  • PP 151

  Hyaluronan is a key player in COVID-19 pathogenesis – mechanisms and treatments

  • Professor Annasara Lenman (Umeå / SE)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 152

  Establishment of a nose-only individual aerosolization device for infection and drug efficacy studies in small animals

  • Dr. Anne Balkema-Buschmann (Greifswald – Insel Riems / DE)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 153

  The efficacy of SARS-CoV-2- specific IgY antibodies in infected hamsters

  • Dr. Mónika Madai (Pécs / HU)

   Antivirals, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 154

  Structural and functional characterization of a novel monoclonal antibody with pan-neutralizing SARS-CoV-2 activity including BQ.1.1 variant

  • Andrea Modrego (Madrid / ES)

   SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 155

  The role of TLR9 signalling in the course of Covid-19

  • Professor Paulina Niedźwiedzka-Rystwej (Szczecin / PL)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 156

  Longitudinal study of CD4+ T cells polarization in individuals with Long-COVID shows a persistent increase in pro-inflammatory populations and a decrease in antiviral response

  • Olivia de la Calle-Jiménez (Madrid / ES)

   Immune response to virus infection, SARS -CoV2 and other coronaviruses
• • Poster Presentation
  • PP 157

  Comparison of entry process of SARS-CoV2 variants into different types of cells

  • Mikołaj Piotrkowski (Gdansk / PL)

   SARS -CoV2 and other coronaviruses, Virus and cancer
• • Poster Presentation
  • PP 158

  The impact of insularity on SARS-CoV-2 diffusion – genetic snapshot of two years of COVID-19 pandemic in Sardinia

  • Dr. Nicole Grandi (Cagliari / IT)

   SARS -CoV2 and other coronaviruses